PPLI delivered a results-day pop that forced the Street's hand — the stock closed Tuesday up 10.4% to $46.43, and analysts moved targets higher almost in lockstep the following morning.
The analyst response was unusually swift and uniform. Four firms raised price targets on August 5, all within hours of each other. Benchmark kept its Buy and lifted to $70 from $60. Truist Securities held its Buy and moved to $62 from $50. UBS, staying Neutral, nudged to $56 from $49. Citizens raised to $54 from $47. The direction is unambiguous — the mean target now sits at $57.40, implying roughly 24% upside from current levels. The bull case centres on the People segment beating EBITDA expectations by 12.6% in the most recent quarter, with the Care.com divestiture clearing the decks for a cleaner, more focused business. Bears point to the residual uncertainty around litigation exposure, MGM visibility, and margin drag from new consumer investment. Neither camp is wrong — the stock's 30-day EPS surprise factor ranks in the 99th percentile, meaning beats have been the pattern, but the valuation still reflects that.
Shorts held their ground through the print and have not retreated meaningfully since. Short interest is 12% of the free float — up around 5% over the past month and essentially unchanged on the week at 0.2% — suggesting the bears are not rushing to cover despite the price jump. The ORTEX short score ticked up to 65.1 on August 4, its highest reading in the recent series, ranking in just the 8th percentile of all stocks (lower percentile = more heavily shorted on a relative basis). The prior earnings-preview note flagged shorts at 11.8% heading into the print; they have edged higher since, not lower. That persistence is notable. Borrow availability remains loose at 517% — well above the 52-week floor of 371% — so new shorts face no supply constraint. Cost to borrow is negligible at 0.51%, up 10% on the week but still barely a rounding error as a carry cost.
Options positioning has actually become less defensive than it was six weeks ago. The put/call ratio has dropped to 2.88, almost a standard deviation below its 20-day average of 3.12 and well off the June highs above 5.0. That drift lower preceded the earnings pop and reflects options traders gradually pricing out downside risk through the run-up to the report. The current reading is still elevated in absolute terms — three puts traded for every call — but the trend is the story: hedging demand has been fading even as short interest held firm.
One institutional footnote worth watching: Helikon Investments entered as a new holder in Q2, disclosing 5.65 million shares — roughly 7.6% of the company — with the entire position reported as new. That makes Helikon the fourth-largest holder behind BlackRock, founder Barry Diller, and Aristeia Capital. Combined with Highsage Ventures adding 419,000 shares in the same period, there has been meaningful accumulation on the long side even as shorts maintained their positions, creating a structure where committed buyers and committed sellers are both well represented in the register.
The next scheduled earnings date is November 10. Between now and then, the key tension is whether shorts — who sat through a 10% day without covering — eventually respond to the revised analyst targets, or whether the bear thesis around structural headwinds to the remaining business lines proves more durable than the post-earnings bounce.
See the live data behind this article on ORTEX.
Open PPLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
